Velcade and Busulfan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Velcade and Busulfan. Common interactions include disturbance in attention among females and basal cell carcinoma among males.
The phase IV clinical study analyzes what interactions people who take Velcade and Busulfan have. It is created by eHealthMe based on reports of 85 people who take Velcade and Busulfan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
85 people who take Velcade and Busulfan together, and have interactions are studied.
What is Velcade?
Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 60,227 Velcade users for its effectiveness, alternative drugs and more.
What is Busulfan?
Busulfan has active ingredients of busulfan. eHealthMe is studying from 12,055 Busulfan users for its effectiveness, alternative drugs and more.
Number of Velcade and Busulfan reports submitted per year:

Common Velcade and Busulfan drug interactions by gender *:
female:
- Disturbance in attention
- Dizziness
- Paraesthesia
- Peripheral sensory neuropathy
- Respiratory tract infection
- Tremor
- Vision blurred
- Weight decreased
- Metastases to abdominal cavity
- Refractory cancer
male:
- Basal cell carcinoma
- Pneumonia
- Aphthous stomatitis
- Asthma
- Back pain
- Blood creatine phosphokinase increased
- Blood creatine phosphokinase mb increased
- Blood glucose fluctuation
- Blood phosphorus decreased
- Bone disorder
Common Velcade and Busulfan drug interactions by age *:
0-1:
n/a
2-9:
- Bone marrow failure
- Cerebral haemorrhage
- Cytomegalovirus infection
- Diarrhoea
- Enterococcal infection
- Graft versus host disease
- Pyrexia
- Sepsis
- White blood cell count decreased
10-19:
- Cholecystitis
- Cholelithiasis
20-29:
n/a
30-39:
- Fatigue
- Visual impairment
- Metastases to abdominal cavity
- Refractory cancer
40-49:
- Congestive cardiomyopathy
- Ejection fraction decreased
- Disturbance in attention
- Dizziness
- Paraesthesia
- Peripheral sensory neuropathy
- Tremor
- Vision blurred
- Weight decreased
- Drug ineffective
50-59:
- Agranulocytosis
- Amnesia
- Anaemia
- Anxiety
- Aortic aneurysm
- Aphthous stomatitis
- Arteriosclerosis
- Asthma
- Back pain
- Blood creatine phosphokinase increased
60+:
- Pneumonia
- Leukaemia
- Diverticulitis
- Deep vein thrombosis
- Musculoskeletal chest pain
- Pulmonary embolism
- Pyrexia
- Agranulocytosis
- Altered state of consciousness
- Amnesia
Common conditions people have *:
- Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 20 people, 23.53%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 7.06%
- Pain: 5 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Velcade and Busulfan?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Velcade and Busulfan:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Velcade side effects:
- Thrombocytopenia (decrease of platelets in blood): 4,936 reports
- Diarrhea: 4,592 reports
- Multiple myeloma (cancer of the plasma cells): 4,065 reports
- Fatigue (feeling of tiredness): 3,901 reports
- Pneumonia: 3,657 reports
- Death: 3,215 reports
- Fever: 2,794 reports
- Weakness: 2,729 reports
Browse all side effects of Velcade:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Busulfan side effects:
- Fever: 727 reports
- Drug ineffective: 618 reports
- Thrombocytopenia (decrease of platelets in blood): 524 reports
Browse all side effects of Busulfan:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Velcade interactions:
- Velcade and Revlimid: 22,045 reports
- Velcade and Dexamethasone: 12,067 reports
- Velcade and Aspirin: 7,889 reports
- Velcade and Zometa: 5,769 reports
- Velcade and Cyclophosphamide: 4,667 reports
- Velcade and Decadron: 3,936 reports
- Velcade and Prednisone: 3,918 reports
- Velcade and Omeprazole: 3,228 reports
- Velcade and Darzalex: 3,088 reports
- Velcade and Lopurin: 2,825 reports
Browse all interactions between Velcade and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Busulfan interactions:
- Busulfan and Fludara: 6,486 reports
- Busulfan and Cyclophosphamide: 5,652 reports
- Busulfan and Methotrexate: 3,463 reports
- Busulfan and Mycophenolate mofetil: 2,553 reports
- Busulfan and Cyclosporine: 2,469 reports
- Busulfan and Tacrolimus: 2,000 reports
- Busulfan and Thiotepa: 1,595 reports
- Busulfan and Fludarabine phosphate: 1,546 reports
- Busulfan and Melphalan: 1,386 reports
- Busulfan and Cytarabine: 1,336 reports
Browse all interactions between Busulfan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bortezomib and busulfan (the active ingredients of Velcade and Busulfan, respectively), and Velcade and Busulfan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Velcade and Busulfan.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Junel Fe 1.5/30 vs. Mili - a second ago
- Prochlorperazine vs. Phenergan - 2 seconds ago
- Comtan vs. Dopamine Hydrochloride - 2 seconds ago
- Simvastatin vs. Pradaxa - 4 seconds ago
- Nadolol vs. Trandate - 5 seconds ago
- Fentanyl-25 vs. Vicodin - 13 seconds ago
- Folate vs. Morphine Sulfate - 16 seconds ago
- Tpn and Febrile Neutropenia - 17 seconds ago
- Esgic vs. Methadone Hydrochloride - 19 seconds ago
- Muscle Spasms in Tessalon, how severe and when it was recovered? - 21 seconds ago